Faithful maintenance and propagation of eukaryotic genomes is ensured by three-step DNA ligation reactions employed by ATP-dependent DNA ligases 1,2 . Paradoxically, when DNA ligases encounter nicked DNA structures with abnormal DNA termini, DNA ligase catalytic activity can generate and/or exacerbate DNA damage through abortive ligation that produces chemically adducted, toxic 5′-adenylated (5′-AMP) DNA lesions [3] [4] [5] [6] (Fig. 1a) . Aprataxin (Aptx) reverses DNA-adenylation but the context for deadenylation repair is unclear. Here we examine the importance of Aptx to RNaseH2-dependent excision repair (RER) of a lesion that is very frequently introduced into DNA, a ribonucleotide. We show that ligases generate adenylated 5′-ends containing a ribose characteristic of RNaseH2 incision. Aptx efficiently repairs adenylated RNA-DNA, and acting in an RNA-DNA damage response (RDDR), promotes cellular survival and prevents S-phase checkpoint activation in budding yeast undergoing RER. Structure-function studies of human Aptx/RNA-DNA/AMP/Zn complexes define a mechanism for detecting and reversing adenylation at RNA-DNA junctions. This involves A-form RNA-binding, proper protein folding and conformational changes, all of which are impacted by heritable APTX mutations in Users may view, print, copy, download and text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms Correspondence: williamsrs@niehs.nih.gov, Tel: 1-919-541-4652. * These authors contributed equally to this work.
generated at RNA-DNA junctions in vivo, we examined if the phenotypes of budding yeast strains with varying capacity to incorporate and repair ribonucleotides were altered by Hnt3 Aptx deficiency (Fig. 2) . A M644G variant of the leading strand replicase, DNA polymerase ε (Pol ε, encoded by the POL2 gene, see Extended Data Table 1 ), has increased capacity to incorporate ribonucleotides into DNA in vitro and in vivo 13, 19 . We generated heterozygous diploids in which one copy of HNT3 was replaced with the NatMX4 marker. Tetrad analysis shows that although HNT3 was dispensable for growth in a wild-type Pol ε (POL2) strain, growth of pol2-M644G hnt3Δ haploids was severely impaired (Fig. 2a) , with macroscopic colonies only observed following extended incubation (Extended Data Fig. 2a ).
We hypothesized that the growth defect of the pol2-M644G hnt3Δ strain is linked to accumulation of persistent adenylated DNA strand breaks generated by DNA ligase processing of RNase H2 incised RNA-DNA junctions (i.e. 5′-AMP RNA-DNA ). To test if RNase H2 activity contributes to the impaired growth of the pol2-M644G hnt3 mutant, we sporulated and dissected a diploid strain homozygous for deletion of the gene encoding the catalytic subunit of RNase H2 (RNH201). Strikingly, deleting RNH201 (rnh201Δ) largely mitigated the growth defect of the pol2-M644G hnt3Δ mutant ( Increased Rnr3 protein level is a sensitive indicator of S-phase checkpoint activation 12, 20 . An elevated level of the Rnr3 subunit of ribonucleotide reductase was detected in pol2-M644G hnt3Δ cells (Fig. 2d, lane 6 ), but was reduced in the triple mutant pol2-M644G hnt3Δ rnh201Δ strain (lane 8) to a level equivalent to that of a pol2-M644G rnh201Δ mutant (lane 7). This suggests that failure of Hnt3 Aptx to deadenylate 5′-AMP RNA-DNA lesions activates the S-phase checkpoint. We also tested hnt3Δ mutant strains for sensitivity to genotoxic stress caused by hydroxyurea (HU). HU treatment increases rNMP incorporation 10 and induces replication fork stalling. Growth of the pol2-M644G hnt3Δ mutant on rich medium was slowed, and survival in the presence of HU was reduced (Extended Data Fig. 2b-c) . Importantly, deleting RNH201 reduced HU-sensitivity to a level comparable to pol2-M644G rnh201Δ cells (Extended Data Fig. 2c ).
Next we examined the consequences of loss of Hnt3 function in yeast strains containing a Pol ε variant with reduced capacity to incorporate ribonucleotides, pol2-M644L 13 . With fewer ribonucleotides in the genome, the pol2-M644L hnt3Δ mutant displayed normal growth (Fig. 2c) , and was unaffected by deleting RNH201. The stark contrast between the consequences of loss of Hnt3 function in the pol2-M644G variant (high genomic ribonucleotides) versus the pol2-M644L mutant (reduced genomic ribonucleotides) is consistent with the model wherein Hnt3 Aptx deadenylates genotoxic AL intermediates arising during RER of ribonucleotides incorporated by Pol ε during DNA replication (Fig.  2e) . A genetic interaction between HNT3 and RNH201 is not apparent in a POL2 strain, possibly because adenylated RNA-DNA junctions may be removed by alternative nucleolytic processing, e.g., mediated by Rad27 Fen1 and Mre11/Rad50/Xrs2 Nbs1 nucleases 8 .
Having implicated Aprataxins in processing 5′-AMP RNA-DNA in vitro and in vivo, we aimed to define the molecular basis for 5′-AMP RNA-DNA processing by human Aptx. Structural analysis of the Schizosaccharomyces pombe Aptx DNA-complex revealed the architecture of the yeast Aptx HIT-Znf domain, and a basis for engagement of DNA ends 3 . However, the molecular basis for the Aptx RNA-DNA interactions, and the mechanism of the Aptx DNA damage direct reversal catalytic reaction remain unclear (see Supplementary Discussion). The minimal catalytic domain of hAptx was mapped to residues 165-342 using deletion mutagenesis, limited proteolysis and deadenylation assays (Extended Data Fig. 3a-c) . We then determined four X-ray crystal structures of 1) an RNA-DNA bound hAptx/5′-AMP/ RNA-DNA/Zn quaternary product complex, 2) a mimic of an adenylated RNA-DNA processing enzymatic transition state, 3) a DNA-only bound hAptx/5′-AMP/DNA/Zn quaternary complex structure and 4) an AOA1 mutant hAptx-K197Q RNA-DNA bound quaternary product complex, (see Supplementary Discussion, Extended Data Table 2 , Extended Data Fig. 3 ).
The Aptx α-β histidine triad (HIT) fold domain 21 assembles with a DNA-binding Znf domain in human Aptx RNA-DNA deadenylase (Fig. 3b , Extended Data Fig. 4-5 ). Close interactions between the HIT and Znf subdomains mold both the active site and the extended RNA-DNA damage-binding surface (Fig. 3b, Extended Data Fig. 5 ). The 5′-adenylate binding pocket and 5′-ribonucleotide interaction surfaces localize to the intersection of the HIT and Znf domains (Fig. 3b-c) . The Aptx-bound RNA-DNA junction is significantly distorted from B-form DNA (Extended Data Fig. 5a ). A two-point nucleic acid-protein interaction induces a ~15° bend in the RNA-DNA by anchoring the exposed 5′-terminal RNA base stack and the 5′-AMP lesion on one side, while engaging the opposite undamaged strand with an array of contacts from the Znf domain (Extended Data Fig. 5d-g ). Biochemical studies revealed Aptx disrupts Watson-Crick base pairing of the adenylated base pair 22 . In our structures, DNA distortions and capping of the RNA-DNA base-stack by the HIT domain N-terminal helix (α1) provide a possible mechanism for un-pairing of the terminal rG:C base pair to gain access to the lesion (Extended Data Fig. 5b-g ). In the DNAonly bound hAptx structure, similar DNA distortions are observed revealing Aptx processes adenylated RNA-DNA and DNA with an analogous modes of substrate engagement (Extended Data Fig. 6 and Supplementary Discussion). Aptx sequesters the 5′-AMP lesion into a hydrophobic active site recess in an extra-helical conformation that is rotated ~180° relative to the RNA-DNA helical axis ( Fig. 3c and Extended Data Fig. 5c ).
RNA-DNA damage detection and reaction chemistry are mediated by four stringently conserved Aptx elements that converge on the 5′-ribonucleotide and 5′AMP-lesion: HIT helix α1, the "histidine triad" HΦHΦH loop (where H=histidine, and Φ denotes a hydrophobic amino acid), the "β2-β3" loop, and Znf helix α3 (Fig. 3c , and Extended Data Fig. 4 ). The two 5′-terminal nucleotides of the damaged strand are bound in an A-form conformation, consistent with an RNA-DNA processing role for the Aprataxins. Multiple contacts bind a C3′-endo sugar-puckered 5′-rG, including ribose sugar-phosphate interactions from Tyr195 and Lys197 of the β2-β3-loop, and aromatic base stacking from Trp167 of HIT-α1 (Fig. 3c , and Extended Data Fig. 3f, 5c) . Cradling of the 2′-hydroxyl of the ribonucleotide with van Der Waals interactions from Tyr195 (β2-β3 loop) and Met256 of the HΦHΦH-loop further anchors the 5′-rG, and aids in aligning the 5′-adenylated RNA terminus for catalysis (Fig. 3c, Extended Data Fig. 5c ). Mutational studies underscore the importance of the β2-β3 loop in substrate binding and catalytic activity (Supplementary Discussion and Extended Data Fig. 6 ).
The first step of the Aptx reaction is proposed to generate a covalent enzyme-AMP intermediate 3, 22 , via an enzyme-nucleic acid transition state that poses a significant challenge to protein structural interrogation. To trap this transition state, we developed reaction conditions under which Aptx activity is inhibited when co-incubated with adenosine, orthovanadate, and a 5′-phosphorylated RNA-DNA junction duplex (Extended Data Fig. 3g-h ). Reaction of hAptx with these reagents in crystallo produced a mimic of the enzyme-RNA/DNA/AMP transition state intermediate for Step 1 of a two-step deadenylation reaction (Fig. 4a , and Extended Data Fig. 3i-j) .
The HΦHΦH loop completely encircles the adenylated 5′-ribonucleotide lesion (Fig. 4) , with His260 covalently bonded to a pentavalent coordinate vanadium atom in the transition state mimic complex ( Fig. 4a and 4d , Extended Data Fig. 3i ). The transition state and product bound structures support a two-step deadenylation reaction initiated by nucleophilic attack of the scissile pyrophosphate by His260 (Fig. 4d) . Protein main-chain amides of Ser255-Met256, and salt bridging from a His201-His262 stabilize this transition state (Fig. 4a) . His251 is ideally positioned to protonate a 5′-P leaving group, and binds 5′-P together with Ser255 and Lys277. In the proposed reaction scheme (Fig. 4d) , Step 1 generates an enzyme-AMP intermediate, which is then resolved via hydrolysis in Step 2. Interestingly, in the product complex, a Na + ion (assigned by oxygen-ion bond lengths) with octahedral coordination binds between Ser255 and 5′-P (Fig. 4b) , suggesting that while Aptx activity is metal-independent, transient solvent cation binding stabilizes the product state, in a matter analogous to third metal binding in DNA polymerase η 23 .
Human Aptx is found in two dramatically different conformations in the product-bound structure. The first conformation (the "assembled active site" Fig. 4b and Extended Data Fig. 7 a-b) has an intact active site characterized by close interactions between HIT-α1 (Leu171 and Trp167) with the HΦHΦH loop, and correct positioning of His260 for catalysis. This state has the His260 imidazole ring hydrogen bonded to the His268 main chain carbonyl oxygen. In the second state (the "disassembled active site"), α1 is displaced by ~4 Å relative to a rearranged HΦHΦH loop, and His260 is flipped out of alignment for nucleophilic attack (compare Fig. 4b and 4c ). Structural overlays (Fig. 4e ) and interpolations between these two states (Supplementary Videos S1 and S2) indicate that concerted conformational rearrangements sculpt the HΦHΦH loop, and may be linked to RNA-DNA substrate binding by α1 and HΦHΦH (Extended data Fig. 7b-e) . We hypothesize that RNA-DNA:protein interactions proximal to the active site regulate active site conformations involving HIT-α1. RNA/DNA-regulated assembly of the Aptx active site may "license" catalytic activity and also prevent inappropriate, non-specific hydrolysis of nucleotides (eg. ATP or ADP hydrolysis). Discrimination against ATP cleavage may be critical for mitochondrial Aptx isoforms that have previously been implicated in DNA damage repair in mitochondria 24 , because off-target catalysis could imbalance nucleotide pool levels.
Both missense and truncating Aptx substitutions are linked to neurodegenerative disease [15] [16] [17] . Based on the human Aptx structures determined here, we predict that the majority of AOA1 mutations (D185E, A198V, P206L, G231E, R247X, V263G, D267G, W279X, W279R and R306X) will decrease protein stability by truncating the polypeptide or by altering the protein-folding core (Extended Data Fig. 8a ). Conformational differences between our RNA-DNA bound structures extend into the protein core (Extended Data Fig.  7a ). Aptx conformational changes may thus be subject to mutagenic modulation in disease. We posit differential impacts on protein folding, active site chemistry and substrate inducedfit active site assembly may all contribute to the variable clinical outcomes observed in patients harboring Aptx defects 17 .
One AOA1 mutation is found in the RNA-DNA substrate interaction cleft (K197Q) and two participate directly in active site chemistry (H201R and H201Q) ( In the wild type protein, Lys197 participates in salt bridging interactions with the 5′-terminal sugar-phosphate backbone and the AMP lesion 2′-hydroxyl. In the mutant, Gln197 is rotated away from the substrate binding pocket, and substitutes direct protein-substrate interactions with through-water nucleic acid binding contacts, thus revealing that distortions in the Aptx-K197Q substrate-binding pocket underlie AOA1.
Our data indicate that during repair of non-canonical ribonucleotides introduced into DNA during replication of the nuclear genome, DNA ligases generate 5′-adenylated RNA-DNA junctions that can elicit a DNA damage checkpoint response unless this is prevented by Aptx deadenylase. In addition to frequent ribonucleotide incorporation by DNA replicases, rNTPs are used by RNA primase to initially synthesize ~ 5% of the nascent lagging strand, and rNTPs are also incorporated during mitochondrial DNA replication 25, 26 , during translesion synthesis 27 , and during DNA repair 28 . Ribonucleotide incorporation during DNA repair may be more prevalent in non-proliferating cells because dNTP concentrations are lower 29, 30 , thereby increasing rNTP:dNTP ratios 30 . Thus, the late onset of AOA1 might partly reflect failure to deadenylate RNA-DNA junctions resulting from ribonucleotides incorporated in DNA transactions occurring over many years in quiescent neurons. It will be important in future work to establish quantitative measures of RNA-DNA adenylation to explore this hypothesis.
In this context, Aptx acts in a nucleic acid transaction that is not exclusively DNA or RNA. Instead, using a reaction mechanism that is finely tuned to operate on RNA-DNA junctions, Aptx acts in an RNA-DNA damage response (RDDR) to protect the genome from a compound insult, a ribosylated, adenylated 5′-terminus. In a broader sense, it seems probable that other enzymes may also modulate the RDDR via the detection, processing and signaling of RNA-DNA-derived structures posing threats to genomic integrity.
METHODS Aptx Protein Expression and Purification
An E. coli codon-optimized coding sequence (GenScript) facilitated robust recombinant overexpression of hAptx. hAptx full-length protein and truncated variants were expressed from pET15b as N-terminal 6xHis-tagged proteins in E. coli BL21(DE3) codon-plus cells (Novagen). Aptx mutations were introduced using the Quickchange system (Stratagene). Cell cultures were grown at 37 °C in LB medium containing ampicillin (100 μg mL −1 ) and chloramphenicol (34 μg mL −1 ) until A 600 reached 0.8 to 1, at which time cells were cooled to 16 °C, and grown for an additional 8-12 hours, without IPTG induction. Cells were lysed by sonication in lysis buffer (50 mM Tris, pH 8.5, 500 mM NaCl, 10 mM imidazole, 0.01 g/L lysozyme, with Roche mini EDTA-free protease inhibitor). The soluble lysate was applied to Ni-NTA column (5 mL, Qiagen) and 6x His-tagged hAptx proteins were eluted in lysis buffer with 300 mM imidazole. The 6xHis-tag was removed with overnight thrombin digestion (50U) (Sigma) at 4°C. Subsequent purification was achieved by size exclusion chromatography (Superdex 75, GE healthcare in 50 mM Tris, pH 7.5, 500 mM NaCl, 5% glycerol, 0.1% β-mercaptoethanol) and cation exchange chromatography on a 5 mL Hi-Trap SP HP (GE Healthcare). S. pombe Aptx was expressed and purified as previously described 3 .
DNA ligation reactions
For DNA ligation experiments, human DNA ligase I (residues 232-919), and DNA ligase III β (residues 170-862) catalytic domains were expressed and purified as described previously 1, 31 . Recombinant T4 DNA ligase and E. coli LigA were obtained from New England Biolabs. Ligation reactions (35 μL) contained DNA ligases (1 μM), 5′-DNA substrate (50 nM, oligonucleotides 1, 2, and 4, Extended Data Fig. 3d ) or 5′-RNA (50 nM, oligonucleotides 1, 2, and 5, Extended Data Fig. 3d ) in 10 mM Tris, pH 7.5, 2 mM MgCl 2 , 1 mM DTT, 1 mM ATP, and 350 ng BSA. 5 μL aliquots of the reaction mixture were taken at 0, 10, 30, 60, 120, 240 min and immediately heat inactivated in 8 M urea and 5% glycerol (5 μL) for 10 min. Ligation reaction products were analyzed on 15% TBE-Urea gels (Invitrogen). Reaction products were analyzed on 15% TBE-Urea gel (Invitrogen). Carboxytetramethylrhodamine (Tamra) labeled reaction products were quantitated on a Typhoon scanner (GE Healthcare).
Limited Proteolysis
Proteolysis reaction mixtures (60 μL) contained hAptx (22 μM), and protease (0.01 mg/mL chymotrypsin or 0.1 mg/mL trypsin) in protease reaction buffer (20 mM Tris, pH 7.5, 450 mM NaCl, 0.1% β-mercaptoethanol). A 10 μl aliquot of the reaction mixture was taken at 0, 5, 15, 30, and 60 min and immediately mixed with 1 mg/mL PMSF (1 μL), and heated in Novex SDS sample buffer (Invitrogen) at 95°C for 10 min. Protease digestion reaction products were analyzed by SDS-PAGE.
Preparation of Adenylated DNA substrates
The adenylated 5′-AMP RNA-DNA substrate was generated by abortive ligation (AL) of human DNA ligase I on the 5′-RNA duplex (oligonucleotides 1, 2, and 5, Extended Data  Fig. 3d ). The 5′-AMP SSB adenylated strand was generated in AL reactions (50 μL) with T4 DNA ligase (2400U) (NEB) on a 5′-SSB duplex (oligonucleotides 1, 3, and 4, Extended Data Fig. 3d) . AL reactions were heat inactivated in 8 M urea at 95 °C for 10 min, and reaction products were fractionated in 20 % TBE-urea gels for purification. The adenylated products were excised from the gel and extracted in 0.3 M sodium acetate pH 5.2 at 37° overnight, followed by desalting on Sep-Pak C18 cartridges (Waters). For Aptx deadenylation analysis, the purified adenylated strands were then re-annealed with the appropriate complementary oligonucleotides (oligonucleotides 1 and 2 to form 5′-AMP RNA-DNA , or oligonucleotides 1 and 3 to form 5′-AMP SSB ).
Aptx Deadenylation Reactions
Deadenylation reactions for Aptx protein-truncation mapping experiments (10 μL) contained 5′-adenylated duplex 5′-AMP SSB (30 nM) and hAptx (0.1 nM to 1 μM) in deadenylation reaction buffer (50 mM Tris, pH 8.0, 40 mM NaCl, 5 mM EDTA, 1 mM DTT, and 5% glycerol). Reactions were incubated at 20 °C for 10 min, and inactivated by heating for 10 min at 100 °C following addition of 10 μL gel loading buffer (8 M urea, 50 mM Tris, pH 7.5, 25 mM EDTA, and 5% glycerol). For time course experiments, deadenylation reactions (40 μl) contained hAptx (2 nM), 5′-adenylated duplex 5′-AMP RNA-DNA (10 nM) or 5′-AMP SSB (10 nM) in deadenylation reaction buffer. 5 μl aliquots of the reaction mixtures were taken at 0, 0.5, 1, 2, 5, 10, 30 min, and immediately heat inactivated in 8 M urea and 5% glycerol (5 μl). Reaction products were analyzed on 15% TBE-Urea gel (Invitrogen). Carboxytetramethylrhodamine (Tamra) labeled reaction products were quantitated on a Typhoon scanner (GE Healthcare). For enzyme kinetic analyses (5 μL reactions) contained hAptx (165-342) (2 nM), 5′-AMP RNA-DNA (7.5 -240 nM) or 5′-AMP SSB (7.5 -480 nM), in deadenylation reaction buffer and were incubated at 20 °C for 5 min. For S. cerevisiae Aptx Hnt3 , 5 μl enzyme kinetics reactions contained Aptx Hnt3 (8 nM, purchased from New England Biolabs), 5′-AMP RNA-DNA (25 -32000 nM) or 5′-AMP SSB (25 -32000 nM), in deadenylation reaction buffer, and were incubated at 20 °C for 5 min. Kinetic parameters were obtained from non-linear regression fitting to a Michaelis-Menten model in Graphpad Prism.
hAptx Crystallization
Initial crystals of a hAptx/DNA/AMP/Zn complex (oligonucleotide 8, Extended Data Fig.  3d ) were grown by mixing complex solution 1 (10 mg ml −1 hAptx-165-342, 1 mM AMP, 1.5:1 DNA-protein ratio, in 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, and 0.1 % β-mercaptoethanol) with an equal volume (300 nL) of the precipitant solution 1 (100 mM Tris, pH 8.5, 20 % w/v polyethylene glycol 10000). Single crystals appeared after two weeks of incubation at 4 °C. Crystals of the hAptx/DNA/AMP product complex (Oligo 9, Extended Data Fig. 3d ) were grown by mixing complex solution 2 (10 mg ml −1 hAptx-165-342, 1 mM AMP, 1:1 DNA-protein ratio, in 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, and 0.1% β-mercaptoethanol) with an equal volume (300 nL) of precipitant solution 2 (150 mM magnesium acetate, 8 % w/v polyethylene glycol 3350). Single crystals appeared overnight after incubation at 4 °C. Crystals of the hAptx/RNA-DNA/AMP product complex (Oligos 6 and 7, Extended Data Fig. 3d ) were grown by mixing complex solution 3 (10 mg ml −1 hAptx-165-342, 1 mM AMP, 1:1 RNA/DNA-protein ratio, in 150 mM NaCl, 20 mM TrisHCl, pH 7.5, and 0.1 % β-mercaptoethanol) with an equal volume (300 nL) of precipitant solution 3 (200 mM potassium sodium tartrate, 20% w/v polyethylene glycol 3350). Single crystals appeared overnight after incubation at 4 °C. Crystals of the hAptx/RNA-DNA/ vanadate/adenosine/Zn transition state complex (Oligos 6 and 7, Extended Data Fig. 3d) were grown by mixing complex solution 4 (10 mg ml −1 hAptx-165-342, 1 mM adenosine, 1:1 RNA/DNA-protein ratio, in 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, and 0.1 % β-mercaptoethanol) with an equal volume (300 nL) of precipitant solution 4 (100 mM sodium formate, 20% w/v polyethylene glycol 3350). The adenosine/RNA-DNA bound crystals were then soaked and reacted for 1 hour at 4 °C in cryoprotectant solution supplemented with 0.5 mM orthovanadate. Crystals of the hAptx-K197Q/RNA-DNA/AMP product complex (Oligos 6 and 7, Extended Data Fig. 3d ) were grown by mixing complex solution 5 (10 mg ml −1 hAptx (165-342)-K197Q, 1 mM AMP, 1:1 RNA/DNA-protein ratio, in 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, and 0.1% β-mercaptoethanol) with an equal volume (300 nL) of precipitant solution 5 (200 mM potassium acetate, 20% w/v polyethylene glycol 3350). All crystals were washed in cryo-protectant (precipitant solutions supplemented with 12% glycerol) and flash frozen in liquid nitrogen for data collection. Diffraction data were processed with HKL2000 32 . 38 . Relevant strain genotypes are listed in Extended Data Table 1 . HNT3 deletion strains were generated by two experimental strategies. For the POL2 (Pol ε-wild type) and pol2-M644G strains, diploids homozygous for the polymerase mutation (and rnh201Δ, where applicable) were made heterozygous for HNT3 (HNT3/hnt3Δ) by PCR-based targeted gene disruption. Deletion of one copy of the HNT3 gene was verified by PCR, haploids were obtained from tetrad dissections and were verified by PCR, appropriate drug-resistance and sequencing of the POL2 locus. Dissection plates were photographed after 3 d growth on rich medium (YPDA: 1 % yeast extract, 2 % bacto-peptone, 250 mg/L adenine, 2 % dextrose, 2 % agar for plates). For the pol2-M644L strains (± RNH201), deletion-replacement of HNT3 was performed via transformation with a PCR product containing the nourseothricin-resistance cassette (natMX4) amplified from pAG25 and flanked by 60 nucleotides of sequence homologous to the intergenic regions upstream and downstream of the HNT3 open reading frame. Transformants that arose from homologous recombination were verified by proper drug-resistance and PCR analysis.
Yeast Strains-Saccharomyces cerevisiae strains used are isogenic derivatives of strain Δ| (-2)|-7B-YUNI300 (MATa CAN1 his7-2 leu2-Δ::kanMX ura3-Δ trp1-289 ade2-1 lys2-DGG2899-2900 agp1::URA3-OR1 or OR2)

hAptx structure solution and refinement
Molecular replacement phases for the hAptx/DNA/AMP/Zn complex (complex 1) to 3.0 Å were obtained by employing a systematic molecular replacement search varying ~190 model and data parameters in PHASER 33 ., and testing multiple molecular constructs based on an S. pombe Aptx-DNA complex (3SZQ) (~ 29 % identity with hAptx) 3 . The successful solution (PHASER TFZ=9.6, LLG=159, Refmac R free = 48.9) contained 4 copies of hAptx in a P2 1 asymmetric unit (ASU). Map quality and molecular replacement phases were improved and extended to 2.5 Å using prime-and-switch density modification with NCS averaging in RESOLVE 34, 35 . The initial model was fit manually in O (v10.0) and partially refined in Refmac 36 . This model was then used for molecular replacement searches to phase the hAptx/RNA-DNA/AMP/Zn (at 1.95 Å, 2 molecules/ASU), hAptx/DNA/AMP/Zn (at 1.85 Å, 2 molecules/ASU), and hAptx-K197Q/RNA-DNA/AMP/Zn product complexes (at 1.90 Å, 2 molecules/ASU). Following autobuilding using PHENIX Autobuild 35 , models were fit manually in Coot 37 and refined in PHENIX 35 . The refined product RNA-DNA complex structure was used to phase the hAptx/RNA-DNA/Adenosine/vanadate/Zn transition state complex (at 2.5 Å). Final structures display excellent geometry (Extended Data Table 2 ) and refinement statistics.
Yeast Strain Growth and HU-sensitivity Analyses-Yeast strains were grown in YPDA at 30 °C. Growth curves were determined in duplicate; a representative plot is displayed. Strain doubling times (D t ) were calculated from measurements of the OD 600nm of cultures in the logarithmic phase of growth in rich medium at 30 °C over a 17 h time-course. D t measurements were made using data from 4 independent biological replicates (8 for the pol2-M644G hnt3δ genotype) and the average D t ± standard deviation is displayed. Statistical analysis (Fig. 2d) was performed in GraphPad Prism. D'Agostino & Pearson omnibus normality test (alpha = 0.05) is passed using doubling time determinations for the pol2-M644G hnt33 strain (n=8). The sample size is too small to run a normality test on the doubling time measurements for the hnt3Δ or pol2-M644G hnt3Δ rnh201Δ strains (n=4 for each). The coefficients of variations in the data are as follows: 11.4 % for the hnt3Δ strain, 19.1 % for the pol2-M644G hnt3Δ strain and 15.2 % for the pol2-M644G hnt3Δ rnh201Δ strain. A spot dilution assay was performed by spotting 10-fold serial dilutions of mid-log phase cultures onto YPDA agar ± 100 mM HU. Plates were incubated at 30 °C and photographed after 3 days of growth. A quantitative HU-survival assay was performed as described previously 12 . Exponentially-growing cells were arrested in G 1 for 3 h with α-factor (5 μg/ml). Approximately 500 cells from each strain were plated onto YPDA agar (untreated) or YPDA agar containing 100 mM HU, incubated for 3-6 days at 30 °C and counted. Percentage survival was calculated as the % of surviving cells compared to the untreated control. The experiment was performed in triplicate, data are displayed as the average ± standard deviation.
Immunoblotting-Whole-cell extracts were prepared from exponentially growing cells as described 12 . The positive control is an extract prepared from wild-type cells treated with 200 mM HU for 3 h. Actin was probed as a loading control. Proteins were resolved on a 10 % Bis-Tris gel (Life Technologies) and western blotting was performed using a 1:1000 dilution of an affinity-purified rabbit polyclonal antibody against Rnr3 (Agrisera; AS09574). The α-actin antibody (Millipore, #MAB1501) was used at 1:1000.
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